NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jame Abraham
Cleveland Clinic - Cleveland / United States
Others
AD Scientific Index ID: 4472913
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jame Abraham's MOST POPULAR ARTICLES
1-)
Reduced lung-cancer mortality with low-dose computed tomographic screeningNational Lung Screening Trial Research TeamNew England Journal of Medicine 365 (5), 395-409, 201187542011
2-)
Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncologyWJ Gradishar, BO Anderson, J Abraham, R Aft, D Agnese, KH Allison, ...Journal of the National Comprehensive Cancer Network 18 (4), 452-478, 20205672020
3-)
Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncologyWJ Gradishar, MS Moran, J Abraham, R Aft, D Agnese, KH Allison, ...Journal of the National Comprehensive Cancer Network 20 (6), 691-722, 20227092022
4-)
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trialM Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...The lancet oncology 18 (12), 1688-1700, 20176912017
5-)
Prognostic significance of the “surprise” question in cancer patientsAH Moss, JR Lunney, S Culp, M Auber, S Kurian, J Rogers, J Dower, ...Journal of palliative medicine 13 (7), 837-840, 20104112010
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept